Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Janssens, I. Buysschaert, P. Zanen, J. Coolen, N. Lays, H. Cuppens, H. Groen, W. Dewever, R. van Klaveren, J. Verschakelen, C. Wijminga, D. Postma, M. Decramer, D. Lambrechts (Leuven, Belgium; Utrecht, Groningen, Rotterdam, Netherlands). The 15q24/25 susceptibility variant for lung cancer and COPD is associated with emphysema. Eur Respir J 2010; 36: Suppl. 54, 3549

Member's Comments

No comment yet.

Related content which might interest you: COPD susceptibility gene on chromosome 4q31 is also associated with lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 SFTPA mutations in interstitial lung disease (ILD) and lung cancer Source: International Congress 2017 – Rare diseases Year: 2017 Polymorphisms associated with lung cancer are closely related to COPD Source: Eur Respir J 2007; 30: Suppl. 51, 136s Year: 2007 The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema Source: Eur Respir J 2011; 38: 924-931 Year: 2011 Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer Source: Eur Respir J, 56 (6) 2002806; 10.1183/13993003.02806-2020 Year: 2020 The association of lung cancer with pulmonary fibrosis Source: ERJ Open Res, 8 (1) 00505-2021; 10.1183/23120541.00505-2021 Year: 2022 Telomere length, COPD and emphysema as risk factors for lung cancer Source: Eur Respir J 2017; 49(1): 1601521; DOI: 10.1183/13993003.01521-2016 Year: 2017 Chronic obstructive pulmonary disease is an independent risk factor for nonsmall cell lung cancer in smokers Source: Eur Respir J 2002; 20: Suppl. 38, 254s Year: 2002 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals Source: Eur Respir J 2011; 37: 791-799 Year: 2011 The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Coexistence of COPD in lung cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001 COPD in patients with lung cancer and smoking Source: Eur Respir J 2005; 26: Suppl. 49, 519s Year: 2005 Late-breaking abstract: The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema Source: Annual Congress 2011 - Molecular pathology and functional genomics of lung disease Year: 2011 COPD, asthma, and lung cancer patients Source: International Congress 2016 – ME13 Smoking cessation in difficult population groups Year: 2016 Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 The Asian experience in co-existing lung cancer and interstitial lung disease Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018 COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer? Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients Source: Eur Respir J, 50 (2) 1700050; 10.1183/13993003.00050-2017 Year: 2017 The burden of emphysema on lung cancer prognosis Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020